Theron Pharmaceuticals is a late preâclinical stage company developing a bestâinâclass bronchodilator for respiratory diseases, including the multiâbillion dollar chronic obstructive pulmonary diseases (COPD) market. Theron has identified several development candidates that have potency, efficacy and long duration of bronchoprotection comparable to tiotropium in guinea pigs and dogs with a rapid onset of action.
Location: United States, California, Sunnyvale